AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Bolt Biotherapeutics, Inc. Director's Dealing 2021

Nov 19, 2021

35210_dirs_2021-11-19_5ad83a38-00aa-4e47-9075-12e55ec63569.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bolt Biotherapeutics, Inc. (BOLT)
CIK: 0001641281
Period of Report: 2021-11-17

Reporting Person: O'CALLAGHAN BRIAN (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned.	0	Direct